MercoPress, en Español
Montevideo, April 20th 2024 - 12:33 UTC
Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners said on Wednesday. Read full article
Commenting for this story is now closed.If you have a Facebook account, become a fan and comment on our Facebook Page!
Get our news on your inbox! Suscribe
Comments
Disclaimer & comment rulesCommenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!